103 related articles for article (PubMed ID: 6540472)
1. The role of fibrinolytic enzymes in inflammation and paranasal mucous membrane.
Kosugi T; Kinjo K; Takagi I; Sueno K; Noda Y; Mihara M
Rhinology; 1984 Jun; 22(2):119-23. PubMed ID: 6540472
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of proactivator from tissue plasminogen activator with low molecular weight in the paranasal mucous membrane.
Kosugi T; Takagi I; Ariga Y; Kinjo K; Matayoshi S; Noda Y
Auris Nasus Larynx; 1982; 9(2):99-104. PubMed ID: 6891585
[TBL] [Abstract][Full Text] [Related]
3. Studies on proactivator from the paranasal mucous membrane in chronic sinusitis.
Kosugi T; Takagi I; Kinjo K; Ura M; Okamoto K; Sueno K; Mihara H
Rhinology; 1983 Dec; 21(4):309-13. PubMed ID: 6686718
[TBL] [Abstract][Full Text] [Related]
4. Some chemical properties of tissue plasminogen activator purified from paranasal mucous membrane.
Kosugi T; Nakamura M; Tsukayama T; Haraguchi S; Noda Y
Rhinology; 1987 Jun; 25(2):129-32. PubMed ID: 3112919
[TBL] [Abstract][Full Text] [Related]
5. Fibrinolytic activity in medium from tissue culture of paranasal mucous membrane.
Kosugi T; Nakamura M; Koja S; Haraguchi S; Noda Y
Rhinology; 1987 Sep; 25(3):195-8. PubMed ID: 3118447
[TBL] [Abstract][Full Text] [Related]
6. Pro-urokinase: physiochemical properties and promotion of its fibrinolytic activity by urokinase and by tissue plasminogen activator with which it has a complementary mechanism of action.
Gurewich V
Semin Thromb Hemost; 1988 Jan; 14(1):110-5. PubMed ID: 3127884
[No Abstract] [Full Text] [Related]
7. Plasminogen activators in human nasal polyps and mucosa.
Larsen K; de Maat MP; Jespersen J
Rhinology; 1997 Dec; 35(4):175-7. PubMed ID: 9532638
[TBL] [Abstract][Full Text] [Related]
8. Urokinase-type plasminogen activator and plasminogen activator inhibitor antigen in tissue extracts of paranasal sinus mucous membranes affected by chronic sinusitis and antrochoanal polyps.
Sunagawa M; Kinjoh K; Nakamura M; Kosugi T
Eur Arch Otorhinolaryngol; 1999; 256(5):237-41. PubMed ID: 10392298
[TBL] [Abstract][Full Text] [Related]
9. Fibrin binding, fibrinolytic and fibrinogenolytic activity of plasminogen activator derived from the paranasal mucous membrane of humans.
Yamashiro Y; Nakamura M; Huang GW; Kosugi T
Laryngoscope; 1993 Feb; 103(2):197-202. PubMed ID: 8426513
[TBL] [Abstract][Full Text] [Related]
10. [The fibrinolytic system and its activators].
Seifried E
Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223
[TBL] [Abstract][Full Text] [Related]
11. Differences in physicochemical properties between tissue plasminogen activators from human paranasal mucous membrane and pig heart.
Kosugi T; Takagi I; Matsuo O; Mihara H; Morimitsu T; Hirano K; Hamaya M
Auris Nasus Larynx; 1981; 8(2):77-86. PubMed ID: 7199907
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of tissue plasminogen activator from paranasal mucous membrane in chronic sinusitis.
Kosugi T; Matsuo O; Mihara H; Hirano K; Hamaya M
Ann Otol Rhinol Laryngol; 1982; 91(1 Pt 1):101-5. PubMed ID: 7041770
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
14. [Endoscopic study on the effects of controlled pressure on the mucosa of the nasal cavity and paranasal sinuses].
Kozlov VS; Shilenkov AA; Shilenkova VV; Zhukov SK
Vestn Otorinolaringol; 1995; (3):42-4. PubMed ID: 7631470
[TBL] [Abstract][Full Text] [Related]
15. [Staging of mucous membrane outcome in operative cavity after functional endoscopic sinus surgery].
Xu G; Li Y; Xie M
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Oct; 34(5):302-5. PubMed ID: 12764831
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of thrombolytic enzymes].
Matsuo O
Rinsho Ketsueki; 1993 Apr; 34(4):395-402. PubMed ID: 8510325
[TBL] [Abstract][Full Text] [Related]
17. The plasminogen activating system in periodontal health and disease.
Kinnby B
Biol Chem; 2002 Jan; 383(1):85-92. PubMed ID: 11928825
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of fibrinolytic enzyme release from human monocytes.
Ragsdale CG; Arend WP
Clin Exp Immunol; 1981 Oct; 46(1):214-24. PubMed ID: 7039879
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
Collen D; Lijnen HR
Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of macrophage plasminogen activator activity by colony-stimulating factors.
Hamilton JA; Stanley ER; Burgess AW; Shadduck RK
J Cell Physiol; 1980 Jun; 103(3):435-45. PubMed ID: 6967488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
